Chargement en cours...

Early Safety Indicators of COVID-19 Convalescent Plasma in 5,000 Patients

Background: Convalescent plasma is the only antibody based therapy currently available for COVID-19 patients. It has robust historical precedence and sound biological plausibility. Although promising, convalescent plasma has not yet been shown to be safe as a treatment for COVID-19. Methods: Thus, w...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:medRxiv
Auteurs principaux: Joyner, Michael, Wright, R. Scott, Fairweather, DeLisa, Senefeld, Jonathon, Bruno, Katelyn, Klassen, Stephen, Carter, Rickey, Klompas, Allan, Wiggins, Chad, Shepherd, John RA, Rea, Robert, Whelan, Emily, Clayburn, Andrew, Spiegel, Matthew, Johnson, Patrick, Lesser, Elizabeth, Baker, Sarah, Larson, Kathryn, Ripoll Sanz, Juan, Andersen, Kylie, Hodge, David, Kunze, Katie, Buras, Matthew, Vogt, Matthew, Herasevich, Vitaly, Dennis, Joshua, Regimbal, Riley, Bauer, Philippe, Blair, Janis, van Buskirk, Camille, Winters, Jeffrey, Stubbs, James, Paneth, Nigel, Casadevall, Arturo
Format: Artigo
Langue:Inglês
Publié: Cold Spring Harbor Laboratory 2020
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7274247/
https://ncbi.nlm.nih.gov/pubmed/32511566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.05.12.20099879
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!